Reference health

Role of epidermal growth factor receptor in vascular structure and function

https://doi.org/10.1097/01.mnh.0000441152.62943.29
CiteStamped reference-health badge
1 of 101 checkable references need attention · checked 2026-07-23

At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.

5 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

References needing attention

marked retracted — notice via Crossref, record curated by Retraction Watch10.2337/db08-0506
EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet–Fed Mice
The 100 checked references that resolve
resolves10.1016/j.cell.2010.06.011
Cell Signaling by Receptor Tyrosine Kinases
resolves10.1016/S1097-2765(03)00350-2
An Open-and-Shut Case? Recent Insights into the Activation of EGF/ErbB Receptors
resolves10.1016/j.atherosclerosis.2005.06.038
The epidermal growth factor receptors and their family of ligands: Their putative role in atherogenesis
resolves10.1097/MNH.0b013e3283503ce9
Novel tyrosine kinase signaling pathways
resolves10.1161/HYPERTENSIONAHA.112.196543
Loss of Epidermal Growth Factor Receptor in Vascular Smooth Muscle Cells and Cardiomyocytes Causes Arterial Hypotension and Cardiac Hypertrophy
resolves10.1002/jcp.22880
Transactivation of EGFR/PI3K/Akt involved in ATP‐induced inflammatory protein expression and cell motility
resolves10.1161/HYPERTENSIONAHA.110.162719
Sphingosine-1-Phosphate-Induced Inflammation Involves Receptor Tyrosine Kinase Transactivation in Vascular Cells
resolves10.1007/s10741-005-2348-y
The Mineralocorticoid Receptor and Oxidative Stress
resolves10.1161/CIRCRESAHA.109.202713
Negative Action of Hepatocyte Growth Factor/c-Met System on Angiotensin II Signaling via Ligand-Dependent Epithelial Growth Factor Receptor Degradation Mechanism in Vascular Smooth Muscle Cells
resolves10.1161/01.CIR.0000048894.99865.02
Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises
resolves10.1161/HYPERTENSIONAHA.109.148783
Elevated Mineralocorticoid Receptor Activity in Aged Rat Vascular Smooth Muscle Cells Promotes a Proinflammatory Phenotype via Extracellular Signal-Regulated Kinase 1/2 Mitogen-Activated Protein Kinase and Epidermal Growth Factor Receptor-Dependent Pathways
resolves10.1161/01.RES.0000258492.96097.47
Mechanisms of Vascular Smooth Muscle Cell Migration
resolves10.1164/rccm.201202-0309OC
A Critical Role for p130Cas in the Progression of Pulmonary Hypertension in Humans and Rodents
resolves10.1016/j.yjmcc.2012.08.022
EBP50 promotes focal adhesion turnover and vascular smooth muscle cells migration
resolves10.1111/j.1365-2613.2009.00700.x
Periadventitial delivery of anti‐EGF receptor antibody inhibits neointimal macrophage accumulation after angioplasty in a hypercholesterolaemic rabbit
resolves10.1016/j.jvs.2008.12.026
Cell migration in response to the amino-terminal fragment of urokinase requires epidermal growth factor receptor activation through an ADAM-mediated mechanism
resolves10.1016/j.yjmcc.2010.12.009
Caveolin-1 negatively regulates a metalloprotease-dependent epidermal growth factor receptor transactivation by angiotensin II
resolves10.1016/j.lfs.2012.06.033
Indoxyl sulfate enhances angiotensin II signaling through upregulation of epidermal growth factor receptor expression in vascular smooth muscle cells
resolves10.1007/s00210-012-0810-7
Nitrosonifedipine ameliorates angiotensin II-induced vascular remodeling via antioxidative effects
resolves10.1124/jpet.109.157552
Angiotensin II-Induced Migration of Vascular Smooth Muscle Cells Is Mediated by p38 Mitogen-Activated Protein Kinase-Activated c-Src through Spleen Tyrosine Kinase and Epidermal Growth Factor Receptor Transactivation
resolves10.1016/j.surg.2012.03.004
Urokinase requires NAD(P)H oxidase to transactivate the epidermal growth factor receptor
resolves10.1161/CIRCRESAHA.109.196691
A Role for Gab1/SHP2 in Thrombin Activation of PAK1
resolves10.1074/jbc.M111.225060
15-Lipoxygenase-1-enhanced Src-Janus Kinase 2-Signal Transducer and Activator of Transcription 3 Stimulation and Monocyte Chemoattractant Protein-1 Expression Require Redox-sensitive Activation of Epidermal Growth Factor Receptor in Vascular Wall Remodeling
resolves10.1093/cvr/cvr308
Nox1 transactivation of epidermal growth factor receptor promotes N-cadherin shedding and smooth muscle cell migration
resolves10.1096/fasebj.12.9.665
Activation of EGF receptor by oxidized LDL
resolves10.1016/j.toxlet.2010.05.002
7-Ketocholesterol and cholesterol-5α,6α-epoxide induce smooth muscle cell migration and proliferation through the epidermal growth factor receptor/phosphoinositide 3-kinase/Akt signaling pathways
resolves10.1007/s00424-007-0211-9
Altered collagen homeostasis in human aortic smooth muscle cells (HAoSMCs) induced by aldosterone
resolves10.1152/ajpendo.00708.2006
Aldosterone-induced EGFR expression: interaction between the human mineralocorticoid receptor and the human EGFR promoter
resolves10.1161/CIRCRESAHA.107.160077
Targeting the Calpain/Calpastatin System as a New Strategy to Prevent Cardiovascular Remodeling in Angiotensin II–Induced Hypertension
resolves10.1038/hr.2011.16
Aldosterone/NaCl-induced renal and cardiac fibrosis is modulated by TGF-β responsiveness of T cells
resolves10.1093/jmcb/mjt030
Connective tissue growth factor is a new ligand of epidermal growth factor receptor
resolves10.1096/fj.12-224907
Profibrotic TGFβ responses require the cooperative action of PDGF and ErbB receptor tyrosine kinases
resolves10.1016/j.cellsig.2013.07.007
Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species
resolves10.1111/j.0022-202X.2004.23478.x
EGFR Enhances Early Healing After Cutaneous Incisional Wounding
resolves10.1096/fj.02-0640fje
Cytochrome P450 2C9‐derived epoxyeicosatrienoic acids induce angiogenesis via cross‐talk with the epidermal growth factor receptor
resolves10.1182/blood-2009-08-236430
Factor XII stimulates ERK1/2 and Akt through uPAR, integrins, and the EGFR to initiate angiogenesis
resolves10.1016/j.surg.2010.03.020
Epidermal growth factor receptor signaling modulates chemokine (CXC) ligand 5 expression and is associated with villus angiogenesis after small bowel resection
resolves10.1152/ajpheart.01018.2010
Angiotensin II-induced process of angiogenesis is mediated by spleen tyrosine kinase via VEGF receptor-1 phosphorylation
resolves10.1161/01.ATV.0000109171.50229.33
Endothelial Nitric Oxide Synthase
resolves10.1074/jbc.M411565200
Resveratrol and Estradiol Rapidly Activate MAPK Signaling through Estrogen Receptors α and β in Endothelial Cells
resolves10.1152/ajpheart.00230.2009
eNOS uncoupling and endothelial dysfunction in aged vessels
resolves10.1161/01.HYP.0000226054.53527.bb
Molecular Mechanism of the Inhibitory Effect of Aldosterone on Endothelial NO Synthase Activity
resolves10.2337/db06-0288
Attenuation of Angiotensin II Signaling Recouples eNOS and Inhibits Nonendothelial NOX Activity in Diabetic Mice
resolves10.1161/ATVBAHA.112.248344
Induction of Angiotensin-Converting Enzyme and Activation of the Renin–Angiotensin System Contribute to 20-Hydroxyeicosatetraenoic Acid–Mediated Endothelial Dysfunction
resolves10.1210/en.2004-1674
Aldosterone Induces Angiotensin Converting Enzyme Gene Expression via a JAK2-Dependent Pathway in Rat Endothelial Cells
resolves10.1152/ajpheart.00526.2010
Epidermal growth factor receptor transactivation by endogenous vasoactive peptides contributes to hyperproliferation of vascular smooth muscle cells of SHR
resolves10.1016/j.cellsig.2011.06.006
Transactivation of epidermal growth factor receptor by enhanced levels of endogenous angiotensin II contributes to the overexpression of Giα proteins in vascular smooth muscle cells from SHR
resolves10.1096/fj.03-0702fje
Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition
resolves10.1161/HYPERTENSIONAHA.110.153619
Epidermal Growth Factor Receptor Mediates the Vascular Dysfunction But Not the Remodeling Induced by Aldosterone/Salt
resolves10.1161/ATVBAHA.111.223537
Consequences of Epidermal Growth Factor Receptor (ErbB1) Loss for Vascular Smooth Muscle Cells From Mice With Targeted Deletion of ErbB1
resolves10.1126/science.7618084
Targeted Disruption of Mouse EGF receptor: Effect of Genetic Background on Mutant Phenotype
resolves10.1093/cvr/cvs369
Induction of oxidative stress by oxidized LDL via meprinα-activated epidermal growth factor receptor in macrophages
resolves10.1161/ATVBAHA.112.256107
Increased Epidermal Growth Factor–Like Ligands Are Associated With Elevated Vascular Nicotinamide Adenine Dinucleotide Phosphate Oxidase in a Primate Model of Atherosclerosis
resolves10.1172/JCI117669
Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaques.
resolves10.1161/ATVBAHA.111.241257
Metalloproteinase Processing of HBEGF Is a Proximal Event in the Response of Human Aortic Endothelial Cells to Oxidized Phospholipids
resolves10.1016/j.ejphar.2011.12.044
Angiotensin AT1 receptor blockers suppress oxidized low-density lipoprotein-derived formation of foam cells
resolves10.1111/j.1365-2567.2011.03541.x
The chemokine CCL18 causes maturation of cultured monocytes to macrophages in the M2 spectrum
resolves10.1016/0014-5793(94)01335-X
Hydrogen peroxide preferentially enhances the tyrosine phosphorylation of epidermal growth factor receptor
resolves10.1016/0092-8674(94)90272-0
Involvement of growth factor receptors in the mammalian UVC response
resolves10.1074/jbc.M011766200
c-Jun N-terminal Kinase Activation by Hydrogen Peroxide in Endothelial Cells Involves Src-dependent Epidermal Growth Factor Receptor Transactivation
resolves10.1186/1742-2094-9-152
c-Src-dependent EGF receptor transactivation contributes to ET-1-induced COX-2 expression in brain microvascular endothelial cells
resolves10.1161/ATVBAHA.109.185801
Thrombin Induces EGF Receptor Expression and Cell Proliferation via a PKC(δ)/c-Src-Dependent Pathway in Vascular Smooth Muscle Cells
resolves10.1016/j.biopha.2010.09.014
The angiotensin receptor blocker, telmisartan, reduces and stabilizes atherosclerosis in ApoE and AT1aR double deficient mice
resolves10.1006/bbrc.1995.1177
Oxidized Low-Density Lipoprotein Stimulates Nitric Oxide Release by Rabbit Aortic Endothelial Cells
resolves10.1161/ATVBAHA.113.301595
Sirolimus Stimulates Vascular Stem/Progenitor Cell Migration and Differentiation Into Smooth Muscle Cells via Epidermal Growth Factor Receptor/Extracellular Signal–Regulated Kinase/β-Catenin Signaling Pathway
resolves10.1093/annonc/mdn047
Remission of diabetes while on sunitinib treatment for renal cell carcinoma
resolves10.2337/dc06-0558
Improvement of Type 2 Diabetes in a Lung Cancer Patient Treated With Erlotinib
resolves10.1056/NEJM200503103521023
Imatinib and Regression of Type 2 Diabetes
resolves10.1016/j.vph.2009.06.008
Early inhibition of EGFR signaling prevents diabetes-induced up-regulation of multiple gene pathways in the mesenteric vasculature
resolves10.1093/cvr/cvq030
GPCR agonist-induced transactivation of the EGFR upregulates MLC II expression and promotes hypertension in insulin-resistant rats
resolves10.2337/db07-0739
Elevated Epidermal Growth Factor Receptor Phosphorylation Induces Resistance Artery Dysfunction in Diabetic <i>db/db</i> Mice
resolves10.1074/jbc.M304913200
Epidermal Growth Factor Receptor Transactivation Is Regulated by Glucose in Vascular Smooth Muscle Cells
resolves10.1016/j.yjmcc.2009.12.010
Role of growth factor receptor transactivation in high glucose-induced increased levels of Gq/11α and signaling in vascular smooth muscle cells
resolves10.1152/ajpcell.00463.2009
AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-δ: implications for vascular disease
resolves10.1073/pnas.0600362103
Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor
resolves10.1016/j.bcp.2008.01.003
Transactivation of epidermal growth factor receptor in vascular and renal systems in rats with experimental hyperleptinemia: Role in leptin-induced hypertension
resolves10.1159/000085904
Diabetes-Induced Renal Vascular Dysfunction Is Normalized by Inhibition of Epidermal Growth Factor Receptor Tyrosine Kinase
resolves10.1161/HYPERTENSIONAHA.112.192500
A Novel Role for Epidermal Growth Factor Receptor Tyrosine Kinase and Its Downstream Endoplasmic Reticulum Stress in Cardiac Damage and Microvascular Dysfunction in Type 1 Diabetes Mellitus
resolves10.1111/j.1474-8673.2009.00426.x
Role of 20‐hydroxyeicosatetraenoic acid in altering vascular reactivity in diabetes
resolves10.1371/journal.pone.0067813
Activation of ErbB2 and Downstream Signalling via Rho Kinases and ERK1/2 Contributes to Diabetes-Induced Vascular Dysfunction
resolves10.1002/dmrr.905
Role of elevated EGFR phosphorylation in the induction of structural remodelling and altered mechanical properties of resistance artery from type 2 diabetic mice
resolves10.1016/j.ajpath.2011.09.016
Chronic Inhibition of Epidermal Growth Factor Receptor Tyrosine Kinase and Extracellular Signal-Regulated Kinases 1 and 2 (ERK1/2) Augments Vascular Response to Limb Ischemia in Type 2 Diabetic Mice
resolves10.1172/JCI111772
Epidermal growth factor, a vascular smooth muscle mitogen, induces rat aortic contraction.
resolves10.1073/pnas.93.10.4957
Hemodynamic effects of epidermal growth factor in conscious rats and monkeys.
resolves10.1016/j.mvr.2009.04.006
Heparin-binding EGF-like growth factor is a potent dilator of terminal mesenteric arterioles
resolves10.1152/ajpheart.01325.2008
Angiotensin II maintains cerebral vascular relaxation via EGF receptor transactivation and ERK1/2
resolves10.1111/j.1474-8673.2004.00333.x
The role of tyrosine kinase‐mediated pathways in diabetes‐induced alterations in responsiveness of rat carotid artery
resolves10.1096/fj.02-0115fje
Epidermal growth factor receptor transactivation mediates the tonic and fibrogenic effects of endothelin in the aortic wall of transgenic mice
resolves10.1161/01.CIR.0000030181.63741.56
Angiotensin II–Induced Cardiac Hypertrophy and Hypertension Are Attenuated by Epidermal Growth Factor Receptor Antisense
resolves10.1111/j.1476-5381.2010.00829.x
α<sub>1</sub>‐Adrenoceptor‐mediated contraction of rat aorta is partly mediated via transactivation of the epidermal growth factor receptor
resolves10.1089/ars.2012.4836
Enhanced Depolarization-Induced Pulmonary Vasoconstriction Following Chronic Hypoxia Requires EGFR-Dependent Activation of NAD(P)H Oxidase 2
resolves10.1371/journal.pone.0077073
The Beneficial Effect of Suramin on Monocrotaline-Induced Pulmonary Hypertension in Rats
resolves10.1161/CIRCULATIONAHA.105.540542
Epidermal Growth Factor Receptor Blockade Mediates Smooth Muscle Cell Apoptosis and Improves Survival in Rats With Pulmonary Hypertension
resolves10.1164/rccm.200811-1682OC
Role of Epidermal Growth Factor Inhibition in Experimental Pulmonary Hypertension
resolves10.1152/ajpheart.01077.2005
Hypoxia and hypoxia-inducible factor-1α promote growth factor-induced proliferation of human vascular smooth muscle cells
resolves10.1165/rcmb.2005-0039OC
Cytokine-Induced Endothelial Arginase Expression Is Dependent on Epidermal Growth Factor Receptor
resolves10.1152/ajplung.00122.2009
Hypoxia-induced proliferation of human pulmonary microvascular endothelial cells depends on epidermal growth factor receptor tyrosine kinase activation
resolves10.1016/j.bbamcr.2007.07.001
HB-EGF induces delayed STAT3 activation via NF-κB mediated IL-6 secretion in vascular smooth muscle cell
resolves10.1002/art.24765
Nuclear autoantigen CENP‐B transactivation of the epidermal growth factor receptor via chemokine receptor 3 in vascular smooth muscle cells
resolves10.1152/ajplung.00287.2010
Thrombospondin-1 opens the paracellular pathway in pulmonary microvascular endothelia through EGFR/ErbB2 activation
The 5 references without a DOI — listed, not checked
no DOI — not checkedR34-4-20140204
no DOI — not checkedR35-4-20140204
no DOI — not checkedR37-4-20140204
no DOI — not checkedR49-4-20140204
no DOI — not checkedR89-4-20140204
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1097/01.mnh.0000441152.62943.29"><img src="https://citestamp.com/citestamped/10.1097/01.mnh.0000441152.62943.29/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1097/01.mnh.0000441152.62943.29/badge.svg)](https://citestamp.com/citestamped/10.1097/01.mnh.0000441152.62943.29)